Kathryn C. Zoon - 24 May 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ S. Scott Lieberman, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
24 May 2022
Transactions value $
$-70,918
Form type
4
Filing time
25 May 2022, 16:12:35 UTC
Previous filing
27 May 2021
Next filing
31 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale $-70,918 -1,996 -13.9% $35.53* 12,381 24 May 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
F2 All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.